ELISA CIP2A anti-

Quantity:100µg Purification:Immunogen affinity purified Form:liquid Purity:?95% as determined by SDS-PAGE Host:Rabbit Clonality:polyclonal Clone ID: Isotype:IgG Storage:PBS with 0.02% sodium azide and 50% glycerol pH 7.3,-20? for 12 months(Avoid repeated freeze / thaw cycles.) Background:Cancerous inhibitor of protein phosphatase 2A (CIP2A) was originally identified as a cellµLar protein phosphatase 2A (PP2A) inhibitor, and has been shown to control oncogenic cellµLar signals by suppressing the tumor suppressor PP2A. CIP2A overexpression has been found in several malignancies including breast cancer, hepatocellµLar carcinoma, gastric cancer, head and neck cancer, colon cancer, prostate cancer and non-small cell lung cancer. CIP2A is a 83~102 kDa cytoplasmic protein. Immunogen:KIAA1524 Synonyms:Cancerous inhibitor of PP2A, CIP2A, KIAA1524, p90, p90 autoantigen, Protein CIP2A Observed MW:102 kDa Uniprot ID:Q8TCG1 Reactivity:, Mouse, Rat Tested Application:ELISA, WB Recommended dilution:WB: 1:500 - 1:2000 Gene ID:57650 Research Area: